Transforming the DNA Diagnostics Market: Industry ..

created a new article

4 d

Transforming the DNA Diagnostics Market: Industry Growth, Size, and Future Trends to 2029 | #dna Diagnostics Market

Transforming the DNA Diagnostics Market: Industry Growth, Size, and Future Trends to 2029

In April 2023, U.S. Food and Drug Administration approved Omisirge (omidubicel), a substantially modified allogeneic (donor) cord blood-based cell therapy to quicken the recovery of neutrophils (a subset of white blood cells) in the body and reduce the risk of infection.

Like

Comment

Share